ClinicalTrials.gg
Enrolling by invitationNCT07451574Updated Jul 20, 2026

Acceptability and Feasibility Study of Non-alcoholic Beverages

An interventional study of Non-alcoholic beer and Sparkling water in Alcohol Use Disorder (AUD), sponsored by Stanford University. Enrolling by invitation at 1 site in United States. Open to participants aged 21 Years to 89 Years. Per ClinicalTrials.gov, last updated 2026-07-20.

Sponsored by Stanford University · Not applicable, Interventional, and Other

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
21 Years to 89 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 12 studies in Alcoholism by Stanford University — 4 open to participants now, 4 under way, none of them phase 3. Alcoholism · Stanford University.

Planned enrollment
6th of 11
60 · median 60
Started
2026
the only one that year
No phase
10 of 12
4 open now
Registered
12th of 12
by date

Among the 12 studies in Alcoholism by Stanford University, this one is the 6th largest by planned enrollment of the 11 interventional ones that give a count, is the only one that started in 2026, is one of 10 with no phase, and was the 12th registered.

Alcoholism

1,678 studies on the registry are indexed under Alcoholism; 333 are open to participants now.

Browse Alcoholism studies →

Open to participants now

4 of the 12 studies in Alcoholism by Stanford University are open now, in 1 country. Recruiting first, the newest first:

By country, each count listing its studies:

All 4 open studies →

Where they have run

Who these studies take

Of the 238 Alcoholism studies recruiting now, 85 (36%) set no upper age limit and 131 (55%) stop at 75 or younger; 9 take children under 18; 64 take healthy volunteers.

This study: 21 Years to 89 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 12 studies in Alcoholism by Stanford University, or all of them as a file.
02

Study summary

This project will elucidate the acceptability and feasibility of incorporating provision of non-alcoholic beers into alcohol use disorder treatment, for patients interested in using non-alcoholic beers as part of their recovery from alcohol use disorder.

03

Conditions studied

  • Alcohol Use Disorder (AUD)

Browse trials for

Keywords

  • non-alcoholic beer
  • alcohol
04

Who can participate

Ages eligible
21 Years to 89 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

Participants will be eligible if they report on the screening survey:

  • living in California and provide a California mailing address (to ship study materials to)
  • consuming ≤42 alcoholic beverages per week (as we seek to provide an equal count of the substitute beverage and budgetary restrictions prevent an amount greater than that)
  • having alcohol use disorder documented with ≥2 symptoms on the Alcohol Symptom Checklist
  • being enrolled in Ria Health treatment
  • having English language fluency

Exclusion criteria

Exclusion Criteria:

  • Individuals will be excluded at the online screener survey stage if they do not meet all of the inclusion criteria.
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
60 participants (estimated)

Study arms

  • Experimental
    Non-alcoholic beer

    Participants will receive non-alcoholic beers (volume matching alcohol volume intake prior to alcohol use disorder treatment enrollment) for 6 weeks.

    Other: Non-alcoholic beer

  • Other
    Sparkling water

    Participants will receive sparkling water (volume matching alcohol volume intake prior to alcohol use disorder treatment enrollment) for 6 weeks.

    Other: Sparkling water

Interventions

  • OtherNon-alcoholic beer

    Participants will receive non-alcoholic beers and will be encouraged to consume the beverages to the extent they find useful/desirable during the 6-week study period.

  • OtherSparkling water

    Participants will receive sparkling water and will be encouraged to consume the beverages to the extent they find useful/desirable during the 6-week study period.

06

What researchers measure

Primary outcomes

  1. Participant Beverage Satisfaction (Acceptability)

    "How satisfied were you with the beverages you received in this study?" with 5-pt scale response options ranging from "Very Unsatisfied" to "Very Satisfied." Higher scores \[split by condition\] will indicate greater acceptability.

    Time frame: Assessed at the end of week 6

  2. Participant Intention to Consume Assigned Beverage in the Future (Acceptability)

    "Do you intend to consume the beverage type you received in the future?" with 5-pt scale response options ranging from "Definitely not" to "Definitely." Higher scores \[split by condition\] will indicate greater acceptability.

    Time frame: Assessed at the end of week 6

  3. Participant Likelihood of Recommending Beverage (Acceptability)

    "Would you recommend the use of the beverage type you received for people who have alcohol use disorder?" with 5-pt scale response options ranging from "Definitely not" to "Definitely." Higher scores \[split by condition\] will indicate greater acceptability.

    Time frame: Assessed at the end of week 6

  4. Screened Out of Contacted (Feasibility)

    Percentage of participants who completed the screening measure out of those who were contacted. Higher percentage will indicate greater feasibility.

    Time frame: Beginning of recruitment to end of recruitment (approximately 3-6 months)

  5. Eligible Out of Screened (Feasibility)

    Percentage of participants who screen eligible out of those who were screened. Higher percentage will indicate greater feasibility.

    Time frame: Beginning of recruitment to end of recruitment (approximately 3-6 months)

  6. Enrolled Out of Eligible (Feasibility)

    Percentage of participants who enrolled out of those who screened eligible. Higher percentage will indicate greater feasibility.

    Time frame: Beginning of recruitment to end of recruitment (approximately 3-6 months)

  7. Retention (Feasibility)

    Percentage of participants who completed the study out of those who enrolled. Higher percentage \[split by condition\] will indicate greater feasibility.

    Time frame: Beginning of recruitment to end of data collection (approximately 3-6 months)

  8. Perception of Beverage Supply (Feasibility)

    Percentage of participants whose response to "How was the supply of beverages you received throughout the study?" is "just right" \[as opposed to "too little" or "too much"\]. Higher percentage \[split by condition\] will indicate greater feasibility.

    Time frame: Assessed at the end of week 6

Secondary outcomes

  1. Average Blood Alcohol Content Across 6 Weeks

    Average blood alcohol content (measured via breathalyzer) across the 6-week period split by condition.

    Time frame: Study weeks 1-6

  2. Change in Blood Alcohol Content Across 6 Weeks

    Slopes of blood alcohol content separated by condition for: a) start of treatment to pre-study and b) during the 6-week study period \[split by condition\].

    Time frame: Treatment entry to week 6

  3. Average Number of Days with Breathalyzer Readings

    Average number of days with breathalyzer readings across the 6-week study.

    Time frame: Assessed at 6 weeks.

  4. Median Number of Breathalyzer Readings Among Days with Readings

    Median number of breathalyzer readings among days with readings across the 6-week study.

    Time frame: Assessed at 6 weeks.

  5. Change in Reported Alcohol Use

    Percentage of participants endorsing use of study-provided beverages who experienced (a) increase in alcohol use (defined as change in average use per week pre-study to average use per week across the study), (b) no change in alcohol use, (c) decrease in alcohol use \[split by condition\].

    Time frame: Baseline to 6 weeks.

  6. Perceived Change in Craving

    Percentage of participants endorsing use of study-provided beverages who reported (a) increased in desire to drink alcohol, (b) no change in desire to drink alcohol, (c) decreased desire to drink alcohol \[split by condition\] in response to the item "When I drink the study provided beverages I experience…Less desire to drink alcohol; No change in my desire to drink alcohol; or More desire to drink alcohol.

    Time frame: Assessed at 6 weeks.

  7. Perceived Change in Alcohol Use

    Percentage of participants endorsing use of study-provided beverages who reported (a) increased in alcohol use, (b) no change in alcohol use, (c) increased alcohol use \[split by condition\] in response to the item "Because I drink the study provided beverages I drink...Less alcohol than I otherwise would; The same amount of alcohol that I otherwise would; or More alcohol than I otherwise would."

    Time frame: Assessed at 6 weeks.

  8. Perceived Impact of Beverages on Recovery

    Percentage of participants who responded to the item "What impact did the study provided beverages have on your recovery from alcohol use disorder?" with (a) Harmful; (b) No impact; or (c) Helpful \[split by condition\].

    Time frame: Assessed at 6 weeks.

07

Study locations

1 site
  • Stanford Prevention Research Center
    Stanford, California 94304, United States
08

References and documents

Individual participant data

Plan to share: Yes — Data will be uploaded to the NIAAA data archive

Supporting information: Analytic code

Time frame: Analytic code, data, and data dictionary will be uploaded upon at the time of primary results submission to an academic journal.

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started May 2026 (actual). Primary completion is estimated for Oct 2026, 5 months after the start.

Of 472 non-industry interventional studies with no phase under Alcoholism, half reached primary completion within 35 months of starting (the median), counting those still running; a quarter within 18 and three quarters within 54. This study's planned 5 months is below that.

Counting every sponsor, half of 495 studies reached it within 33 months; a quarter within 17 and three quarters within 52.

How these figures are worked out, and which studies are left out of them.

Registered
Feb 27, 2026
First posted
Mar 5, 2026
StartActual
May 14, 2026
Primary completionEst.
Oct 2026
CompletionEst.
Nov 2026
Last update
Jul 20, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jul 20, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07451574
Responsible party
Molly Anne Bowdring (Instructor, Stanford University) — Principal investigator
First posted
Mar 5, 2026
Start date
May 14, 2026
Primary completion
Oct 2026 (estimated)
Completion
Nov 2026 (estimated)
Last update
Jul 20, 2026

Study contacts

Molly A Bowdring, PhD
principal investigator · Stanford University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion